跳至主要内容
临床试验/CTRI/2022/11/046964
CTRI/2022/11/046964尚未招募未知

Exploring the utility of artificial intelligence augmented functional connectomics approach in brain tumors: a prospective cohort study

BrainSight Technology Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Glioma diagnosis
  • Eligible for surgical resection

排除标准

  • Anyone <18 and >60 years of age
  • History of primary neurological disorders including seizure disorders/pre-existing disorders of development and degenerative disorders involving structural changes
  • Primary/pre-existing development and degenerative disorder involving structural changes
  • Primary/pre-existing Movement, Vision and speech disorders
  • Surgery in adjunct with cranial radiotherapy
  • Follow-up cases
  • Patients with contraindications to magnetic resonance imaging scanning
  • Pregnant women
  • Cases of meningioma

研究者

发起方
BrainSight Technology Pvt. Ltd.

相似试验